Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B

Table 1 Correlation of the GPR, APRI, and FIB-4 (mean ± SD) with the baseline characteristics of patients

Parameter		GPR	APRI	FIB-4
	Mean ± SD	r	r	r	P
TBIL (μmol/L)	22.70 ± 28.53	0.275	0.205	0.258	< 0.01
AST (IU/L)	81.71 ± 146.11	0.183	0.644	0.834	< 0.01
ALT (IU/L)	125.71 ± 246.43	0.113	0.547	0.764	< 0.01
GGT (IU/L)	225.21 ± 1008.88	0.779	0.222	0.235	< 0.01
PLT count (109/L)	160.82 ± 66.61	-0.285	-0.285	-0.26	< 0.01
GPR	0.73 ± 1.79	1.000	0.385	0.255	< 0.01
APRI	65.44 ± 140.77	0.385	1.000	0.847	< 0.01
FIB-4	417.93 ± 1367.85	0.255	0.847	1.000	< 0.01

TBIL: Total bilirubin; AST: Aspartate transaminase; ALT: Alanine transaminase; GGT: Gamma-glutamyltranspeptidase; PLT: Platelet; GPR: the gamma-glutamyltranspeptidase-to-platelet ratio; APRI: (AST)-to-platelet ratio index; FIB-4: Fibrosis-4.